Work

DX-8951f, a Hexacyclic Camptothecin Analog, on a Daily-Times-Five Schedule: A Phase I and Pharmacokinetic Study in Patients With Advanced Solid Malignancies

Year: 2000

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2000.18.17.3151

Authors: Eric K. Rowinsky, Thomas R. Johnson, Charles E. Geyer, Lisa A. Hammond, S. Gail Eckhardt, Ronald Drengler, Leslie Smetzer, John Coyle, Jinee Rizzo, Garry Schwartz, Anthony Tolcher, Daniel D. Von Hoff, Robert L. De Jager

Institutions: Brooke Army Medical Center, The University of Texas at San Antonio Health Science Center

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1954914693

FWCI: 1.809

Cites: 36

Cited by: 47

Related to: 10